Company attributes
Venture Capital Firm attributes
Other attributes
MVM Life Science Partners is a venture capital firm from London that invests in start-up, early stage, mid-stage, and late-stage ventures. Founded in 1997, it specializes in venture funding, post-IPO equity, and debt financing. It typically invests in Series C and Series B. Its portfolio companies include Avantium Technologies, Avantium Technologies, Providence Medical Technology, AmbioPharm, and Horizon Discovery. It manages four funds totalling more than US$700 million.
This company invests in high growth healthcare businesses, such as those in the medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, and digital health sectors. It has offices in Boston and London.